The role of ripc in preventing organ damage, inflammation and oxidative stress during lower limb DSA: A randomised controlled trial

Abstract

Background and Aims : Diagnostic digital subtraction angiography (DSA) and DSA with percutaneous transluminal angioplasty (DSA-PTA) are common procedures for diagnosing and treating symptomatic lower extremity arterial disease (LEAD). However, organ damage following DSA and DSA-PTA is often under-recognised and hence undiagnosed. The aim of the current study was to assess the effect of remote ischemic preconditioning (RIPC) intervention on the organ damage markers profile, oxidative stress and inflammation biomarkers in LEAD patients undergoing DSA and DSA-PTA procedure.